Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"Quisinostat"”.
-
Molecular Determinants of Diffuse Midline Glioma of the Pons Vulnerability to the Histone Deacetylase Inhibitor, Quisinostat
… deacetylase inhibitors (HDACi), exemplified by Quisinostat, have exhibited clinical efficacy across various cancer types, inducing apoptosis, growth arrest, and regression of oncogenic phenotypes. Our study sets out to probe the effects of Quisinostat on DMGs, with a keen focus on its influence …
-
Identification of new therapeutic targets for undifferentiated pleomorphic sarcoma
… to assess potential synergistic effects. Quisinostat was the most promising compound, exhibiting the greatest synergistic effects with doxorubicin, and was selected to investigate its on-target and functional effects on proliferation and apoptosis. The results of quisinostat combined with …
-
Metabolism and CNS Distribution of Selected Histone Deacetylase Inhibitors
… potent HDACIs, panobinostat, vorinostat, and quisinostat, following systemic administration. We characterized the systemic pharmacokinetics and CNS distributional kinetics of these compounds in wild-type and transgenic mice lacking p-glycoprotein (P-gp) and/or breast cancer resistance protein …
-
Κλινική σημασία των αναστολέων των Αποακετυλασών των Ιστονών (Histone Deacetylase – HDAC ) στο κακόηθες μελάνωμα
… Αποτελέσματα: Το Vorinostat, το Panobinostat, το Quisinostat και το Entinostat είναι οι πρώτοι HDAC αναστολείς που έχουν χρησιμοποιηθεί σε ασθενείς με μεταστατικό μελάνωμα. Το Vorinostat και το Entinostat έδειξαν μεγαλύτερη αποτελεσματικότητα όταν εφαρμόστηκαν σε συνδυασμό με άλλους παράγοντες …
-
Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia
… the potential of a second-generation HDI, quisinostat, to reverse glucocorticoid resistance in ALL xenografts, reaching the conclusion that HDIs are likely to be of limited utility. Therefore, to identify novel glucocorticoid sensitisers, I performed a cell-based high throughput screening …